We dont know that yet. Whats ahead Rosenthal at Cleveland Clinic Florida says he likes having these drugs in his toolbox
The reason is that drugs deliver synthetic appetite-suppressing chemical messengers like GLP-1, GIP, and glucagon agonists at levels astronomically higher than normally produced by the body
For high BMI patients with limited mobility or GLP-1 non-responders, sema-bima might be a better option Durability - is there a one-and-done solution for weight control
These changes contribute to lower luminal pH, enhanced epithelial barrier integrity, and reduced mucosal inflammation (Gibson and Shepherd, 2010)
Groups at genuine risk of deficiency include vegans, older adults, people with pernicious anaemia, those on long-term metformin, and individuals who have had gastric surgery